Long-acting technologies
38 articles
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. More
LAT CAB: Two New Members
The LAT CAB added two new members: Giten Khwairakpam, from Thailand, and Bakyt Myrzaliev, from Kyrgyzstan. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More
